-
公开(公告)号:KR840001617B1
公开(公告)日:1984-10-11
申请号:KR800002947
申请日:1980-07-25
Applicant: CIBA GEIGY AG
Inventor: TARCSAY LAJOS , BASCHANG GERHAR , HARTMANN ALBERT
-
公开(公告)号:KR840001689B1
公开(公告)日:1984-10-15
申请号:KR840003993
申请日:1984-07-06
Applicant: CIBA GEIGY AG
Inventor: BASHANG GERHARD , TARCSAY LAJAS , STANEK JAROSLAR , HARTMANN ALBERT
IPC: C07H15/00
-
公开(公告)号:KR840001687B1
公开(公告)日:1984-10-15
申请号:KR800003903
申请日:1980-10-11
Applicant: CIBA GEIGY AG
Inventor: BASCHANG GERHARD , TARCSAY LAJOS , STANEK JAROSLAV , HARTMANN ALBERT
IPC: C07H15/00
-
公开(公告)号:KR850000064B1
公开(公告)日:1985-02-15
申请号:KR840005882
申请日:1984-09-25
Applicant: CIBA GEIGY AG
Inventor: HARTMANN ALBERT , BASCHANG GERHARD , WACKER OSKAR
-
公开(公告)号:KR850000063B1
公开(公告)日:1985-02-15
申请号:KR840005880
申请日:1984-09-25
Applicant: CIBA GEIGY AG
Inventor: HARTMANN ALBERT , BASCHANG GERHARD , WACKER OSKAR
-
公开(公告)号:MX9203368A
公开(公告)日:1992-09-01
申请号:MX9203368
申请日:1992-06-25
Applicant: CIBA GEIGY AG
Inventor: TARCSAY LAJOS , BASCHANG GERHARD , HARTMANN ALBERT , STANEK JAROSLAV
IPC: C07H13/00 , A61K38/00 , A61K38/14 , A61K39/39 , A61P37/04 , C07K1/06 , C07K1/113 , C07K9/00 , C07K14/52 , C07K14/53 , C07K14/535 , C07K5/06
Abstract: The invention relates to pharmaceutical preparations that contain an antibiotic and a muramylpeptide of the formula I or a salt thereof, to processes for their manufacture and to a method for increasing the antibiotic effectiveness of antibiotics. (I) In the formula I, X represents carbonyl or carbonyloxy, R1 represents optionally substituted alkyl or aryl, R2, R3, R4 and R6 represent hydrogen or lower alkyl, R5 represents hydrogen, optionally substituted lower alkyl, cycloalkyl, aryl or nitrogen-containing heterocyclyl, or R4 and R5 together represent also C3-C4 alkylene, R7 represents hydrogen or free, esterified or amidated carboxyl, one of the radicals A1 and A2 represents a radical of the formula II and the other of the radicals A1 and A2 represents optionally substituted or functionally modified hydroxy or amino. (II) In the formula II, T represents NH or O, Y represents an optionally substituted alkylene group that can also be interrupted by oxycarbonyl or iminocarbonyl, W represents hydrogen and Z represents an optionally esterified or etherified 1,2-dihydroxyethyl or 2-hydroxyethyl group, or W and Z represent an optionally esterified or etherified hydroxymethyl group.
-
公开(公告)号:NO167394C
公开(公告)日:1991-10-30
申请号:NO840263
申请日:1984-01-24
Applicant: CIBA GEIGY AG
Inventor: BASCHANG GERHARD , WACKER OSKAR , HARTMANN ALBERT
IPC: C07C20060101 , C07K5/08 , C07K5/10 , C07K7/06
-
公开(公告)号:DK161025C
公开(公告)日:1991-10-28
申请号:DK319480
申请日:1980-07-24
Applicant: CIBA GEIGY AG
Inventor: TARCSAY LAJOS , BASCHANG GERHARD , HARTMANN ALBERT , STANEK JAROSLAV
IPC: C07H13/00 , A61K38/00 , A61K38/14 , A61K39/39 , A61P37/04 , C07K1/06 , C07K1/113 , C07K9/00 , C07K14/52 , C07K14/53 , C07K14/535 , C07K5/02 , C07H15/04 , C07F9/09
Abstract: The invention relates to pharmaceutical preparations that contain an antibiotic and a muramylpeptide of the formula I or a salt thereof, to processes for their manufacture and to a method for increasing the antibiotic effectiveness of antibiotics. (I) In the formula I, X represents carbonyl or carbonyloxy, R1 represents optionally substituted alkyl or aryl, R2, R3, R4 and R6 represent hydrogen or lower alkyl, R5 represents hydrogen, optionally substituted lower alkyl, cycloalkyl, aryl or nitrogen-containing heterocyclyl, or R4 and R5 together represent also C3-C4 alkylene, R7 represents hydrogen or free, esterified or amidated carboxyl, one of the radicals A1 and A2 represents a radical of the formula II and the other of the radicals A1 and A2 represents optionally substituted or functionally modified hydroxy or amino. (II) In the formula II, T represents NH or O, Y represents an optionally substituted alkylene group that can also be interrupted by oxycarbonyl or iminocarbonyl, W represents hydrogen and Z represents an optionally esterified or etherified 1,2-dihydroxyethyl or 2-hydroxyethyl group, or W and Z represent an optionally esterified or etherified hydroxymethyl group.
-
公开(公告)号:DK161025B
公开(公告)日:1991-05-21
申请号:DK319480
申请日:1980-07-24
Applicant: CIBA GEIGY AG
Inventor: TARCSAY LAJOS , BASCHANG GERHARD , HARTMANN ALBERT , STANEK JAROSLAV
IPC: C07H13/00 , A61K38/00 , A61K38/14 , A61K39/39 , A61P37/04 , C07K1/06 , C07K1/113 , C07K9/00 , C07K14/52 , C07K14/53 , C07K14/535 , C07K5/02 , C07H15/04 , C07F9/09
Abstract: The invention relates to pharmaceutical preparations that contain an antibiotic and a muramylpeptide of the formula I or a salt thereof, to processes for their manufacture and to a method for increasing the antibiotic effectiveness of antibiotics. (I) In the formula I, X represents carbonyl or carbonyloxy, R1 represents optionally substituted alkyl or aryl, R2, R3, R4 and R6 represent hydrogen or lower alkyl, R5 represents hydrogen, optionally substituted lower alkyl, cycloalkyl, aryl or nitrogen-containing heterocyclyl, or R4 and R5 together represent also C3-C4 alkylene, R7 represents hydrogen or free, esterified or amidated carboxyl, one of the radicals A1 and A2 represents a radical of the formula II and the other of the radicals A1 and A2 represents optionally substituted or functionally modified hydroxy or amino. (II) In the formula II, T represents NH or O, Y represents an optionally substituted alkylene group that can also be interrupted by oxycarbonyl or iminocarbonyl, W represents hydrogen and Z represents an optionally esterified or etherified 1,2-dihydroxyethyl or 2-hydroxyethyl group, or W and Z represent an optionally esterified or etherified hydroxymethyl group.
-
10.
公开(公告)号:FI79330C
公开(公告)日:1989-12-11
申请号:FI832639
申请日:1983-07-20
Applicant: CIBA GEIGY AG
Inventor: HARTMANN ALBERT , WACKER OSKAR , BASCHANG GERHARD , TARCSAY LAJOS
-
-
-
-
-
-
-
-
-